Biotech

News

Syncona aims Slingshot at biotech's 'translational gap'

UK-based life science investor Syncona has launched a new company – Slingshot Therapeutics – with a mission to find promising projects in academia and translate them into full-blown develop

News

Metsera gets $215m for obesity trials, and other financings

If any further evidence were needed for the insatiable investor appetite for companies with obesity assets, look no further than New York start-up Metsera.

News

Nasdaq debutante Septerna swells its IPO to $331m

Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million.

News

Alpha-9's $175m third-round heads latest biotech financings

Radiopharma start-up Alpha-9 Oncology has closed a sizeable third investment round, heading a list of recent financings that also feature Axonis, Kivu Bio, SynOx, Agomab, and Blue Earth The

News

City Therapeutics' $135m debut, and other bio financing news

Our round-up of recent biotech financings features a strong first round for City Therapeutics, a new RNAi venture led by biotech doyen John Maraganore, and additional cash for Purespring, J

R&D